Rotella Capital Management, Inc. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$93,000
+3.3%
16,300
+35.2%
0.03%
-59.5%
Q2 2015$90,000
-67.4%
12,058
-66.9%
0.07%
-69.0%
Q4 2014$276,000–36,473–0.24%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2015.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders